©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 110312
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110312
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110312
Table 3 Response to treatment of patients with autoimmune hepatitis according to age of diagnosis, n (%)
| Younger than 60 years (n = 57) | Older than 60 years (n = 40) | P value | |
| Aminotransferases | |||
| Normalization at 6 months | 26 (46) | 17 (43) | 0.761 |
| Normalization at 12 months | 42 (74) | 29 (70) | 0.690 |
| Time to normalization (months) [median (IQR)] | 6 (4-10) | 6 (4.5-8) | 0.799 |
| Immunoglobulin G | |||
| Normalization at 6 months | 38 (67) | 20 (56) | 0.440 |
| Time to normalization (months) [median (IQR)] | 5 (3-7) | 4.5 (2.5-7) | 0.960 |
- Citation: Delgado J, Fuentes M, Simian D, Poniachik J, Urzúa Á. Impact of age on autoimmune hepatitis: A comparative study of patients diagnosed before and after sixty. World J Hepatol 2025; 17(12): 110312
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/110312.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.110312